BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:REQUEST X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:W. Europe Standard Time BEGIN:STANDARD DTSTART:16011028T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10 TZOFFSETFROM:+0200 TZOFFSETTO:+0100 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010325T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3 TZOFFSETFROM:+0100 TZOFFSETTO:+0200 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20200818T024140Z DTEND;TZID="W. Europe Standard Time":20201012T123000 DTSTAMP:20200818T024140Z DTSTART;TZID="W. Europe Standard Time":20201012T113000 LAST-MODIFIED:20200818T024140Z LOCATION:UEG Week Virtual congress platform DESCRIPTION:Please join us for a Takeda-organised virtual symposium during UEG Week Virtual 2020\n\nCan Flexible Treatment Administration Impact Outcomes in Inflammatory Bowel Disease?\n\nMonday\, 12 October\, 11:30-12:30 pm CET\n\nSpeakers: Charlie Lees (Chair)\, Edouard Louis\, Severine Vermeire\n\nThe Takeda-sponsored symposium will be accessible through the UEG Week Virtual congress platform. PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Can Flexible Treatment Administration Impact Outcomes in Inflammatory Bowel Disease? TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000C05D5332E774D601000000000000000 01000000054A7F8AF32FEBD4CB99D0D06A13A71EA X-ALT-DESC;FMTTYPE=text/html:

 \;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR